½ÃÀ庸°í¼­
»óǰÄÚµå
1609719

ÀϺ»ÀÇ ½Å°æÇ÷°ü ±â±â ½ÃÀå º¸°í¼­ : Á¦Ç°, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ªº°(2024-2032³â)

Japan Neurovascular Devices Market Report by Product, Application (Ischemic Stroke, Aneurysm, Arteriovenous Malformation and Fistulas, Stenosis, and Others), End User, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 118 Pages | ¹è¼Û¾È³» : 5-7ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀϺ»ÀÇ ½Å°æÇ÷°ü ±â±â ½ÃÀå ±Ô¸ð´Â 2023³â 1¾ï 7,110¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2032³â±îÁö ½ÃÀå ±Ô¸ð°¡ 3¾ï 1,860¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2024³âºÎÅÍ 2032³â±îÁö 7.4%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ±â¼ú ¹ßÀü, ½Å°æÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, ´ú ħ½ÀÀûÀÎ Ä¡·á¸¦ ¼±È£ÇÏ´Â °í·ÉÈ­ µîÀÌ ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

  • ÀϺ»ÀÇ ½Å°æÇ÷°ü ±â±â ½ÃÀåÀº Áö±Ý±îÁö ¾î¶»°Ô ¼ºÀåÇØ¿Ô°í, ¾ÕÀ¸·Î ¾î¶»°Ô ¹ßÀüÇÒ °ÍÀΰ¡?
  • COVID-19°¡ ÀϺ» ½Å°æÇ÷°ü ±â±â ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº?
  • ÀϺ»ÀÇ ½Å°æÇ÷°ü ±â±â ½ÃÀå Á¦Ç°º° ½ÃÀå ÇöȲÀº?
  • ÀϺ» ½Å°æÇ÷°ü ±â±â ½ÃÀåÀÇ ¿ëµµº° ½ÃÀå ÇöȲÀº?
  • ÀϺ» ½Å°æÇ÷°ü ±â±â ½ÃÀåÀÇ ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀå ÇöȲÀº?
  • ÀϺ» ½Å°æÇ÷°ü ±â±â ½ÃÀåÀÇ °¡Ä¡»ç½½¿¡´Â ¾î¶² ´Ü°è°¡ Àִ°¡?
  • ÀϺ» ½Å°æÇ÷°ü ±â±â ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀΰú °úÁ¦´Â ¹«¾ùÀϱî?
  • ÀϺ» ½Å°æÇ÷°ü ±â±â ½ÃÀåÀÇ ±¸Á¶¿Í ÁÖ¿ä ±â¾÷Àº?
  • ÀϺ»ÀÇ ½Å°æÇ÷°ü ±â±â ½ÃÀå¿¡¼­ÀÇ °æÀïÀº ¾î´À Á¤µµÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
  • ½ÃÀå ÃßÁ¤
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ÀϺ»ÀÇ ½Å°æÇ÷°ü ±â±â ½ÃÀå : ¼­·Ð

  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
  • ¾÷°è µ¿Çâ
  • °æÀï Á¤º¸

Á¦5Àå ÀϺ»ÀÇ ½Å°æÇ÷°ü ±â±â ½ÃÀå ±¸µµ

  • °ú°Å ¹× ÇöÀç ½ÃÀå µ¿Çâ(2018-2023³â)
  • ½ÃÀå ¿¹Ãø(2024-2032³â)

Á¦6Àå ÀϺ»ÀÇ ½Å°æÇ÷°ü ±â±â ½ÃÀå : Á¦Ç°º° ºÐ¼®

  • ³ú »öÀü¼ú ¹× µ¿¸Æ·ù ÄÚÀÏ »öÀü µð¹ÙÀ̽º
  • ³úÇ÷°ü ¼ºÇü¼ú ¹× ½ºÅÙÆ® À¯Ä¡ ½Ã½ºÅÛ
  • ½Å°æ Ç÷Àü Á¦°Å µð¹ÙÀ̽º
  • Áö¿ø µð¹ÙÀ̽º

Á¦7Àå ÀϺ»ÀÇ ½Å°æÇ÷°ü ±â±â ½ÃÀå : ¿ëµµº° ºÐ¼®

  • ÇãÇ÷¼º ³úÁ¹Áß
  • µ¿¸Æ·ù
  • µ¿Á¤¸Æ±âÇü ¹× ´©°ø(AVM)
  • ÇùÂø
  • ±âŸ

Á¦8Àå ÀϺ»ÀÇ ½Å°æÇ÷°ü ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº° ºÐ¼®

  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ŭ¸®´Ð
  • ±âŸ

Á¦9Àå ÀϺ»ÀÇ ½Å°æÇ÷°ü ±â±â ½ÃÀå : °æÀï ±¸µµ

  • °³¿ä
  • ½ÃÀå ±¸Á¶
  • ½ÃÀå ±â¾÷ Æ÷Áö¼Å´×
  • ÁÖ¿ä ¼º°ø Àü·«
  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ Æò°¡ »óÇÑ

Á¦10Àå ÁÖ¿ä ±â¾÷ °³¿ä

Á¦11Àå ÀϺ»ÀÇ ½Å°æÇ÷°ü ±â±â ½ÃÀå : ¾÷°è ºÐ¼®

  • ¼ºÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀΰú ±âȸ
  • PorterÀÇ Five Forces ºÐ¼®
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå ºÎ·Ï

LSH 24.12.23

Japan neurovascular devices market size reached US$ 171.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 318.6 Million by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032. Technological progress, a growing incidence of neurovascular conditions, and an aging population that favors less invasive treatments represent some of the key factors driving the market.

Neurovascular devices are medical instruments specifically designed for the diagnosis and treatment of disorders affecting the blood vessels and nervous system within the brain and spinal cord. They are meticulously manufactured using advanced materials and precision engineering methods to ensure their safety and effectiveness. These devices offer substantial benefits by facilitating minimally invasive procedures, thereby reducing patient discomfort, hospitalization durations, and complications. Neurovascular devices have a wide range of applications in addressing various conditions, including aneurysms, arteriovenous malformations, and ischemic strokes. The categories of neurovascular devices encompass stents, embolic coils, flow diverters, and catheters. Stents provide support to maintain blood vessel integrity, while embolic coils assist in blocking blood flow to treat aneurysms. Flow diverters are employed to redirect blood flow away from weakened vessel areas, and catheters enable the targeted delivery of treatments to affected regions.

Japan Neurovascular Devices Market Trends:

The Japan market for neurovascular devices is significantly influenced by the rising incidence of neurovascular disorders, particularly among the elderly population. As life expectancy continues to increase, so does the prevalence of conditions like ischemic strokes and cerebral aneurysms, necessitating advanced medical interventions. Concurrently, technological advancements in neurovascular devices are reshaping the landscape of interventional neurology. Innovations such as flow-diverting stents and detachable coils are augmenting the effectiveness and safety of neurovascular procedures, garnering interest from healthcare providers and patients alike. Furthermore, the growing recognition of the importance of early diagnosis and treatment for neurovascular disorders is driving market expansion. Besides this, public health campaigns and initiatives centered on stroke awareness and the benefits of timely intervention are boosting patient referrals and treatment rates. Additionally, favorable reimbursement policies and the development of healthcare infrastructure in emerging markets are widening access to neurovascular interventions, propelling market growth on a wide scale. Other factors, including extensive research and development (R&D) efforts undertaken by key industry players and an increasing level of awareness among the general populace, are anticipated to propel the regional market in the coming years.

Japan Neurovascular Devices Market Segmentation:

Product Insights:

  • Cerebral Embolization and Aneurysm Coiling Devices
  • Embolic Coils
  • Flow Diverters
  • Liquid Embolic Agents
  • Cerebral Angioplasty and Stenting Systems
  • Carotid Artery Stents
  • Embolic Protection Devices
  • Neurothrombectomy Devices
  • Clot Retrieval Devices
  • Suction Devices
  • Vascular Snares
  • Support Devices
  • Micro Catheters
  • Micro Guidewires

Application Insights:

  • Ischemic Stroke
  • Aneurysm
  • Arteriovenous Malformation and Fistulas (AVM)
  • Stenosis
  • Others

End User Insights:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan neurovascular devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan neurovascular devices market?
  • What is the breakup of the Japan neurovascular devices market on the basis of product?
  • What is the breakup of the Japan neurovascular devices market on the basis of application?
  • What is the breakup of the Japan neurovascular devices market on the basis of end user?
  • What are the various stages in the value chain of the Japan neurovascular devices market?
  • What are the key driving factors and challenges in the Japan neurovascular devices?
  • What is the structure of the Japan neurovascular devices market and who are the key players?
  • What is the degree of competition in the Japan neurovascular devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Neurovascular Devices Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Neurovascular Devices Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Neurovascular Devices Market - Breakup by Product

  • 6.1 Cerebral Embolization and Aneurysm Coiling Devices
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Embolic Coils
      • 6.1.3.2 Flow Diverters
      • 6.1.3.3 Liquid Embolic Agents
    • 6.1.4 Market Forecast (2024-2032)
  • 6.2 Cerebral Angioplasty and Stenting Systems
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Carotid Artery Stents
      • 6.2.3.2 Embolic Protection Devices
    • 6.2.4 Market Forecast (2024-2032)
  • 6.3 Neurothrombectomy Devices
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2018-2023)
    • 6.3.3 Market Segmentation
      • 6.3.3.1 Clot Retrieval Devices
      • 6.3.3.2 Suction Devices
      • 6.3.3.3 Vascular Snares
    • 6.3.4 Market Forecast (2024-2032)
  • 6.4 Support Devices
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2018-2023)
    • 6.4.3 Market Segmentation
      • 6.4.3.1 Micro Catheters
      • 6.4.3.2 Micro Guidewires
    • 6.4.4 Market Forecast (2024-2032)

7 Japan Neurovascular Devices Market - Breakup by Application

  • 7.1 Ischemic Stroke
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 Aneurysm
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Arteriovenous Malformation and Fistulas (AVM)
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)
  • 7.4 Stenosis
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2018-2023)
    • 7.4.3 Market Forecast (2024-2032)
  • 7.5 Others
    • 7.5.1 Historical and Current Market Trends (2018-2023)
    • 7.5.2 Market Forecast (2024-2032)

8 Japan Neurovascular Devices Market - Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Clinics
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Forecast (2024-2032)
  • 8.4 Others
    • 8.4.1 Historical and Current Market Trends (2018-2023)
    • 8.4.2 Market Forecast (2024-2032)

9 Japan Neurovascular Devices Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Neurovascular Devices Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦